Market research
VTI.AU Visioneering Technologies, Inc
AU AUD Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 4M
- P/E ratio
- Not available
- Analyst target
- 0.66
- Dividend yield
- Not available
- Beta
- 1.87
Profile
Company facts
- Exchange
- AU
- Currency
- AUD
- Sector
- Healthcare
- Industry
- Medical Devices
- ISIN
- AU000000VTI2
- Market cap
- 4M
- P/E ratio
- Not available
- Analyst target
- 0.66
- Dividend yield
- Not available
- Beta
- 1.87
About
About Visioneering Technologies, Inc
Visioneering Technologies, Inc., a medical device company, engages in the design, manufacture, sale, and distribution of contact lenses in North America, Europe, and the Asia-Pacific. Its flagship product is NaturalVue, a multifocal 1-day contact lens for adults with presbyopia and children with myopia. The company was incorporated in 2008 and is headquartered in Alpharetta, Georgia.
Visit company websiteCommunity
Investor discussion
1 comment
Sign in to join the VTI.AU discussion.
5 years, 5 months ago
Visioneering Technologies, Inc is currently in a long term uptrend where the price is trading 490.9% above its 200 day moving average.
From a valuation standpoint, the stock is 99.3% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 1.8.
Visioneering Technologies, Inc's total revenue sank by 9.9% to $3M since the same quarter in the previous year.
Its net income has increased by 31.1% to $-4M since the same quarter in the previous year.
Finally, its free cash flow grew by 67.7% to $-968K since the same quarter in the previous year.
Based on the above factors, Visioneering Technologies, Inc gets an overall score of 4/5.